PCGEM1 and prostate carcinoma: In contrast, another two prostate-specific lncRNAs (PCGEM1 and PCA3) are overexpressed in prostate cancer and promote the cell proliferation ability and inhibit the cell apoptosis ability of prostate cancer cells [36–39].